Literature DB >> 17005996

Cholestasis and hypercholesterolemia in SCD1-deficient mice fed a low-fat, high-carbohydrate diet.

Matthew T Flowers1, Albert K Groen, Angie Tebon Oler, Mark P Keller, Younjeong Choi, Kathryn L Schueler, Oliver C Richards, Hong Lan, Makoto Miyazaki, Folkert Kuipers, Christina M Kendziorski, James M Ntambi, Alan D Attie.   

Abstract

Stearoyl-coenzyme A desaturase 1-deficient (SCD1(-/-)) mice have impaired MUFA synthesis. When maintained on a very low-fat (VLF) diet, SCD1(-/-) mice developed severe hypercholesterolemia, characterized by an increase in apolipoprotein B (apoB)-containing lipoproteins and the appearance of lipoprotein X. The rate of LDL clearance was decreased in VLF SCD1(-/-) mice relative to VLF SCD1(+/+) mice, indicating that reduced apoB-containing lipoprotein clearance contributed to the hypercholesterolemia. Additionally, HDL-cholesterol was dramatically reduced in these mice. The presence of increased plasma bile acids, bilirubin, and aminotransferases in the VLF SCD1(-/-) mice is indicative of cholestasis. Supplementation of the VLF diet with MUFA- and PUFA-rich canola oil, but not saturated fat-rich hydrogenated coconut oil, prevented these plasma phenotypes. However, dietary oleate was not as effective as canola oil in reducing LDL-cholesterol, signifying a role for dietary PUFA deficiency in the development of this phenotype. These results indicate that the lack of SCD1 results in an increased requirement for dietary unsaturated fat to compensate for impaired MUFA synthesis and to prevent hypercholesterolemia and hepatic dysfunction. Therefore, endogenous MUFA synthesis is essential during dietary unsaturated fat insufficiency and influences the dietary requirement of PUFA.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17005996     DOI: 10.1194/jlr.M600203-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  31 in total

1.  Dietary fructose exacerbates hepatocellular injury when incorporated into a methionine-choline-deficient diet.

Authors:  Michael K Pickens; Hisanobu Ogata; Russell K Soon; James P Grenert; Jacquelyn J Maher
Journal:  Liver Int       Date:  2010-06-08       Impact factor: 5.828

Review 2.  Physiological insights gained from gene expression analysis in obesity and diabetes.

Authors:  Mark P Keller; Alan D Attie
Journal:  Annu Rev Nutr       Date:  2010-08-21       Impact factor: 11.848

Review 3.  Stearoyl-coenzyme A desaturase 1 inhibition and the metabolic syndrome: considerations for future drug discovery.

Authors:  J Mark Brown; Lawrence L Rudel
Journal:  Curr Opin Lipidol       Date:  2010-06       Impact factor: 4.776

4.  Diet-induced lipid accumulation in phospholipid transfer protein-deficient mice: its atherogenicity and potential mechanism.

Authors:  Calvin Yeang; Shucun Qin; Kailian Chen; David Q-H Wang; Xian-Cheng Jiang
Journal:  J Lipid Res       Date:  2010-06-11       Impact factor: 5.922

5.  Interleukin-6 derived from cutaneous deficiency of stearoyl-CoA desaturase- 1 may mediate metabolic organ crosstalk among skin, adipose tissue and liver.

Authors:  Sabrina N Dumas; Chang-An Guo; Jason K Kim; Randall H Friedline; James M Ntambi
Journal:  Biochem Biophys Res Commun       Date:  2018-11-22       Impact factor: 3.575

6.  Increased lipid synthesis and decreased β-oxidation in the liver of SHR/NDmcr-cp (cp/cp) rats, an animal model of metabolic syndrome.

Authors:  Shizuyo Tanaka; Tohru Yamazaki; Satoshi Asano; Atsushi Mitsumoto; Daisuke Kobayashi; Naomi Kudo; Yoichi Kawashima
Journal:  Lipids       Date:  2013-09-18       Impact factor: 1.880

7.  Low hepatic stearoyl-CoA desaturase 1 activity is associated with fatty liver and insulin resistance in obese humans.

Authors:  N Stefan; A Peter; A Cegan; H Staiger; J Machann; F Schick; C D Claussen; A Fritsche; H-U Häring; E Schleicher
Journal:  Diabetologia       Date:  2008-02-20       Impact factor: 10.122

8.  Inverse association between carbohydrate consumption and plasma adropin concentrations in humans.

Authors:  Joseph R Stevens; Monica L Kearney; Marie-Pierre St-Onge; Kimber L Stanhope; Peter J Havel; Jill A Kanaley; John P Thyfault; Edward P Weiss; Andrew A Butler
Journal:  Obesity (Silver Spring)       Date:  2016-08       Impact factor: 5.002

9.  Inhibition of stearoyl-coenzyme A desaturase 1 dissociates insulin resistance and obesity from atherosclerosis.

Authors:  J Mark Brown; Soonkyu Chung; Janet K Sawyer; Chiara Degirolamo; Heather M Alger; Tam Nguyen; Xuewei Zhu; My-Ngan Duong; Amanda L Wibley; Ramesh Shah; Matthew A Davis; Kathryn Kelley; Martha D Wilson; Carol Kent; John S Parks; Lawrence L Rudel
Journal:  Circulation       Date:  2008-09-15       Impact factor: 29.690

10.  Absence of stearoyl-CoA desaturase-1 ameliorates features of the metabolic syndrome in LDLR-deficient mice.

Authors:  Marcia L E MacDonald; Roshni R Singaraja; Nagat Bissada; Piers Ruddle; Russell Watts; Joanna M Karasinska; William T Gibson; Catherine Fievet; Jean E Vance; Bart Staels; Michael R Hayden
Journal:  J Lipid Res       Date:  2007-10-24       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.